Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can AI write better pregnancy advice than a script?

NCT ID NCT07883993

Knowledge-focused Sponsor: Nivi, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 20, 2026 · Last updated Oct 21, 2026 · Updated 1 time

Summary

Researchers are comparing two versions of a free WhatsApp chatbot that answers pregnancy questions for women in India. One version replies with prepared answers, while the other uses generative AI to write responses based on reviewed maternal health materials and to flag possible emergencies. About 2,500 pregnant women in three Indian states join the study and are assigned at random to one version. The study tracks how often women use the chatbot, how useful they find it, how they decide when to seek care, and whether they attend prenatal visits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a WhatsApp pregnancy chatbot that uses generative AI to answer questions
What this could lead to
If the AI version keeps women more engaged and helps them seek care at the right time, it could offer a low-cost way to support pregnant women in places with limited health services.
What could go wrong
The AI may give unhelpful or confusing answers, and women may not use either chatbot much. The study measures engagement and behavior, not pregnancy outcomes, so any benefit to health remains uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 2,500 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older * Currently pregnant with gestational age between 10 and 20 weeks, by self report * Located in India * Self-reported female gender * Regular access to a smartphone with WhatsApp * Able to communicate in English, Hindi, or Assamese * New user of the askNivi chatbot, with study enrollment occurring during onboarding * Consents to participate and completes the baseline survey Exclusion Criteria: * Age under 18 years * Not currently pregnant * Gestational age under 10 weeks or over 20 weeks at enrollment * Located outside India * Self-reported male gender or gender diverse identity, as the chatbot is designed specifically for women * No regular access to a smartphone, or unable to use WhatsApp * Unable to communicate in Hindi, English, or Assamese * Self-reported high-risk pregnancy requiring specialized care beyond the scope of the chatbot * Previous user of the askNivi chatbot * Healthcare provider or researcher involved in maternal health

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Maternal health are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Maternal health Pregnancy Prenatal care

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AskNivi Private Limited

    Kalyān, Maharashtra, 421201, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.